Something About Company
Syncona is a FTSE 250 company focused on investing in and building global leaders in life sciences. We operate as a hands-on investment fund, working closely with world class scientists to found, build and fund world class companies to deliver transformational treatments to patients. We currently have 10 companies in our portfolio, largely focused on cell and gene therapy, and are always actively looking for new opportunities.
